AMH FIA 검사 시장 보고서 : 동향, 예측, 경쟁 분석(-2031년)
AMH FIA Test Market Report: Trends, Forecast and Competitive Analysis to 2031
상품코드 : 1818145
리서치사 : Lucintel
발행일 : 2025년 09월
페이지 정보 : 영문 150 Pages
 라이선스 & 가격 (부가세 별도)
US $ 3,850 ₩ 5,587,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 4,650 ₩ 6,749,000
PDF (2 Users License) help
PDF 보고서를 동일 사업장에서 2명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 5,350 ₩ 7,764,000
PDF (5 Users License) help
PDF 보고서를 동일 사업장에서 5명까지 이용할 수 있는 라이선스입니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 7,050 ₩ 10,232,000
PDF (Corporate License) help
PDF 보고서를 기업 내 모든 분이 이용할 수 있는 라이선스입니다. 이용 인원에 제한은 없으나, 국내에 있는 사업장만 해당되며, 해외 지점 등은 포함되지 않습니다. PDF 파일은 DRM(디지털 저작권 관리 시스템)이 장착되어 있습니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 AMH FIA 검사 시장의 미래는 의료와 과학 연구 시장에서의 기회로 유망시되고 있습니다. 세계의 AMH FIA 검사 시장은 2025-2031년에 CAGR 11.5%로 성장할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 불임 및 생식 보건에 대한 인식 증가, 진단 기술의 발전, 의료 투자 증가 등입니다.

AMH FIA 검사 시장의 새로운 동향

AMH FIA 검사 시장은 생식 의료 기술의 발전, 불임에 대한 사회적 태도의 변화, 진단 툴의 개선으로 인해 몇 가지 중요한 추세에 있습니다. 이러한 추세는 불임 검사 및 치료 옵션을 재구성하고 난소 예비력 평가에 대한 광범위한 접근성과 정확성을 향상시키고 있습니다. 이러한 동향을 이해하는 것은 시장 기회를 활용하고자 하는 이해관계자들에게 필수적입니다.

이러한 추세는 AMH FIA 검사 시장이 가임력 보존에 대한 수요 증가, 기술 발전, 신흥 시장에서의 채택 확대로 인해 빠르게 진화하고 있음을 보여줍니다. ART 시술에 AMH 검사가 통합되고 여성 생식 건강에 대한 관심이 높아지면서 시장이 재편되고 있으며, 혁신과 성장의 새로운 기회를 창출하고 있습니다.

AMH FIA 검사 시장의 최근 동향

AMH FIA 검사 시장은 기술 발전, 가임력 보존에 대한 수요 증가, 검사에 대한 접근성 확대로 인해 빠르게 발전하고 있습니다. 이러한 발전은 전 세계 의료 시스템의 변화와 여성의 생식 건강에 대한 강조를 반영하고 있습니다. 다음은 AMH FIA 검사 시장 전망를 형성하는 5 가지 주요 개발입니다.

이러한 발전은 기술 발전, 불임 치료 수요 증가, 선진국과 신흥 시장 모두에서 접근성 확대로 인해 AMH FIA 검사 시장이 지속적으로 성장하고 있음을 보여줍니다. 이러한 추세가 지속된다면, AMH 검사 시장은 더욱 확대될 것이며, 혁신과 생식 헬스케어 개선의 새로운 기회를 제공할 것입니다.

목차

제1장 개요

제2장 시장 개요

제3장 시장 동향과 예측 분석

제4장 세계의 AMH FIA 검사 시장(유형별)

제5장 세계의 AMH FIA 검사 시장(용도별)

제6장 지역 분석

제7장 북미의 AMH FIA 검사 시장

제8장 유럽의 AMH FIA 검사 시장

제9장 아시아태평양의 AMH FIA 검사 시장

제10장 기타 지역의 AMH FIA 검사 시장

제11장 경쟁 분석

제12장 기회와 전략 분석

제13장 밸류체인 전체에 걸친 주요 기업의 기업 개요

제14장 부록

KSA
영문 목차

영문목차

The future of the global AMH FIA test market looks promising with opportunities in the medical and scientific research markets. The global AMH FIA test market is expected to grow with a CAGR of 11.5% from 2025 to 2031. The major drivers for this market are the increasing awareness of fertility & reproductive health, the advancements in diagnostic technology, and the increased healthcare investments.

Emerging Trends in the AMH FIA Test Market

The AMH FIA test market is undergoing several key trends, driven by advancements in reproductive health technologies, shifts in societal attitudes toward fertility, and improvements in diagnostic tools. These trends are reshaping the landscape of fertility testing and treatment options, leading to broader access and enhanced precision in assessing ovarian reserve. Understanding these trends is essential for stakeholders looking to capitalize on market opportunities.

These trends indicate that the AMH FIA test market is evolving rapidly, with increased demand for fertility preservation, technological advancements, and wider adoption across emerging markets. The integration of AMH testing in ART procedures and the growing focus on women's reproductive health are reshaping the market and creating new opportunities for innovation and growth.

Recent Developments in the AMH FIA Test Market

The AMH FIA test market has been evolving rapidly, with significant advancements in technology, increased demand for fertility preservation, and expanding access to testing. These developments reflect shifts in healthcare systems globally and a greater emphasis on women's reproductive health. Below are five key developments that are shaping the future of the AMH FIA test market.

These developments highlight the ongoing growth of the AMH FIA test market, driven by advancements in technology, increased demand in fertility care, and broader access in both developed and emerging markets. As these trends continue, the market for AMH testing will likely expand further, offering new opportunities for innovation and improved reproductive healthcare.

Strategic Growth Opportunities in the AMH FIA Test Market

The AMH FIA test market presents several strategic growth opportunities across various applications, particularly in fertility assessment, healthcare diagnostics, and assisted reproductive technologies. These opportunities reflect the expanding demand for reproductive health services and the increasing awareness of fertility preservation. Below are key growth opportunities in the AMH FIA test market, each offering potential for further market expansion.

These growth opportunities reflect the expanding demand for AMH testing across fertility, women's health, and emerging markets. By capitalizing on these opportunities, companies in the AMH FIA test market can drive expansion and further innovate in reproductive healthcare solutions.

AMH FIA Test Market Driver and Challenges

The AMH FIA test market is shaped by various drivers and challenges that influence its growth and adoption. Technological advancements, rising awareness about fertility issues, and regulatory factors all play a significant role in shaping the market's trajectory. However, challenges such as cost, access to testing, and regulatory hurdles also impact market growth. Below are the key drivers and challenges in the AMH FIA test market.

The factors responsible for driving the AMH FIA test market include:

1. Growing Fertility Awareness: The increasing awareness of fertility issues is a major driver for the AMH FIA test market. More individuals and couples are seeking fertility treatments, which drives demand for diagnostic tests like AMH to assess ovarian reserve and guide fertility care.

2. Technological Advancements in Diagnostics: Technological innovations, such as automated testing systems and improved test sensitivity, are driving the growth of the AMH FIA test market. These advancements make AMH testing faster, more accurate, and more accessible, leading to wider adoption in fertility clinics and healthcare centers.

3. Rising Demand for Fertility Preservation: As more women delay childbirth and seek fertility preservation options like egg freezing, the demand for AMH testing is increasing. AMH tests are essential in assessing ovarian reserve, making them a critical tool in fertility preservation decisions.

4. Government Support for Fertility Services: Governments in many regions are providing support for fertility treatments through subsidies and insurance coverage. This has led to an increase in the availability of AMH testing as part of assisted reproductive technologies like IVF, fostering market growth.

5. Integration with Assisted Reproductive Technologies (ART): The growing use of ART procedures such as IVF and IUI has driven demand for AMH testing. By assessing ovarian reserve, AMH tests help tailor ART treatments for better success rates, further integrating them into fertility care protocols.

Challenges in the AMH FIA test market are:

1. High Cost of Testing: The cost of AMH testing can be a significant barrier, especially in developing regions where healthcare spending is limited. The high cost of tests may restrict access to a larger demographic, limiting market expansion.

2. Limited Access in Rural Areas: Despite the increasing availability of AMH testing in urban areas, access to these tests remains limited in rural and remote regions, especially in emerging markets. This disparity hinders broader market adoption and access to fertility care.

3. Regulatory Hurdles: The regulatory landscape surrounding AMH testing is complex, with varying standards across different regions. Stringent regulations and approvals can delay the market entry of new testing technologies and hinder growth in certain regions.

The drivers and challenges impacting the AMH FIA test market reflect a dynamic landscape of opportunities and obstacles. Rising fertility awareness, technological advancements, and government support are driving growth, while cost, access issues, and regulatory hurdles present challenges. These factors will continue to shape the market's evolution.

List of AMH FIA Test Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies AMH FIA test companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the AMH FIA test companies profiled in this report include-

AMH FIA Test Market by Segment

The study includes a forecast for the global AMH FIA test market by type, application, and region.

AMH FIA Test Market by Type [Value from 2019 to 2031]:

AMH FIA Test Market by Application [Value from 2019 to 2031]:

AMH FIA Test Market by Region [Value from 2019 to 2031]:

Country Wise Outlook for the AMH FIA Test Market

The AMH FIA (Anti-Mullerian Hormone Fluorescent Immunoassay) test market has seen notable advancements globally, with significant changes in the U.S., China, Germany, India, and Japan. These developments reflect shifts in healthcare trends, increasing awareness of fertility issues, and advancements in diagnostic technology. The AMH test, used to assess ovarian reserve, is gaining popularity in fertility clinics and healthcare settings as an essential tool for assessing fertility potential. These regions are adopting the test at varying rates, influenced by regional healthcare infrastructure, demand for reproductive health solutions, and the availability of advanced technologies.

Features of the Global AMH FIA Test Market

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

Table of Contents

1. Executive Summary

2. Market Overview

3. Market Trends & Forecast Analysis

4. Global AMH FIA Test Market by Type

5. Global AMH FIA Test Market by Application

6. Regional Analysis

7. North American AMH FIA Test Market

8. European AMH FIA Test Market

9. APAC AMH FIA Test Market

10. ROW AMH FIA Test Market

11. Competitor Analysis

12. Opportunities & Strategic Analysis

13. Company Profiles of the Leading Players Across the Value Chain

14. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기